Irving Institute for Clinical and Translational Research
The Irving Institute for Clinical and Translational Research is Columbia University's NIH-funded CTSA hub, providing research support services, training programs, pilot funding, and a network of core research resources to CUIMC investigators and academic partners to accelerate translational science.
- Company typePrivate
- Founded2004
- HeadquartersNew York, United States
- Headcount11–50
- GTM typeB2B
- OfferingServices
What Irving Institute for Clinical and Translational Research does
The Irving Institute for Clinical and Translational Research is Columbia University's designated Clinical and Translational Science Awards (CTSA) hub, operating within Columbia University Irving Medical Center to accelerate the translation of scientific discoveries from bench to bedside to community. Established in 2004 (with the related Irving Scholars program dating to 1987) and headquartered at 630 West 168th Street in New York City, the institute serves primarily Columbia University Irving Medical Center investigators, junior faculty, doctoral and postdoctoral trainees, and community partners engaged in clinical and translational research. Its mission is operationalized through a network of twelve core research resources and a portfolio of training, pilot funding, and digital navigation programs.
The institute's core technology and product surface is built around an integrated research infrastructure. Key technical components include the Biostatistics, Epidemiology, and Research Design (BERD) Resource, the Biomedical Informatics Resource (BMIR), the Biomarkers Core Laboratory, the Community Engagement Core Resource, the Clinical Research Resource, the Regulatory Knowledge and Support and Ethics Resource, the Pilot and Collaborative Studies Resource, and dedicated cores for bionutrition, exposomics, recruitment and retention, network capacity, and training and education. Digital products include the newly launched Plan Your Research online navigation tool (2025), a Visualization Web Apps suite of eleven statistical/visualization tools, and a Trial Design and Conduct Web Apps suite of three design tools. Training products include the Columbia Summer Research Institute (CSRI), Systematic Review & Meta-analysis Workshop, Irving Scholars Program, KL2 Scholars Mentored Career Development Award, TL1 Training Programs, and Precision Medicine Fellows. Pilot award programs cover the Translational Therapeutics Accelerator, Precision Medicine, Collaborative and Multidisciplinary Pilot Research (CaMPR), and Community-Based Participatory Research (CBPR).
The institute is a private non-profit academic research unit of Columbia University and is not independently incorporated or publicly traded. Its primary revenue mechanism is the NIH NCATS CTSA hub grant (UL1 TR001873), providing approximately $75 million in funding to advance healthcare discoveries. Revenue is supplemented by philanthropy (notably the Irving family endowment supporting the Irving Scholars program, approximately $1 million annually for recent cohorts), external research grants routed through investigators (including a $21 million PCORI award to Dr. Jennifer Woo Baidal), and modest fee revenue from external training programs such as CSRI (~$22,478 per participant) and the Systematic Review workshop ($349 per participant). Most core services are provided at no cost to eligible Columbia investigators, with fee-based models applied selectively to external participants. The institute operates with a small administrative headcount of 23 employees against a much larger distributed research funding throughput.
Irving Institute for Clinical and Translational Research firmographics
Firmographics- Name
- Irving Institute for Clinical and Translational Research
- Legal name
- Irving Institute for Clinical and Translational Research
- Website
- https://irvinginstitute.columbia.edu
- Company type
- Private
- Founded year
- 2004
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- The Irving Institute for Clinical and Translational Research is Columbia University's NIH-funded CTSA hub, providing research support services, training programs, pilot funding, and a network of core research resources to CUIMC investigators and academic partners to accelerate translational science.
- Ownership category
- akta.pro rank
Irving Institute for Clinical and Translational Research industry classification
Industry- Product category
- Academic Clinical and Translational Research Services
- NAICS
- Research and Development in Biotechnology (except Nanobiotechnology) (541714), Scientific Research and Development Services (5417)
- SIC
- Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Translational Medicine & Biomarkers (HLAIALAF)
- akta.pro secondary industry
- Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF) (HLAGAJAM)
Keywords
Where Irving Institute for Clinical and Translational Research is headquartered
LocationHeadquarters
- HQ city
- New York
- HQ country
- United States
- HQ region
- North America
Offices4 records
Markets served
Irving Institute for Clinical and Translational Research business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales
Revenue model
- NIH CTSA Grant Funding: Primary funding through the National Center for Advancing Translational Sciences (NCATS) at the National Institutes of Health, providing approximately $75 million to advance healthcare discoveries. This grant supports the institute's core operations and research programs.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Annual | Columbia Summer Research Institute (CSRI) Program |
| Other | Annual | Systematic Review & Meta-analysis Workshop |
Go-to-market motion1 record
Distribution channels3 records
Marketing channels5 records
Irving Institute for Clinical and Translational Research product offering
Product offeringCore offering
The Irving Institute for Clinical and Translational Research serves as Columbia University's Clinical and Translational Science Awards (CTSA) hub, providing integrated research support services, training programs, pilot funding mechanisms, and digital navigation tools to accelerate the translation of scientific discoveries from bench to bedside to community. Its core offerings include the Plan Your Research online tool, visualization and trial design web applications, multiple career development awards (Irving Scholars, KL2, TL1, Precision Medicine Fellows), pilot award programs (TRx, Precision Medicine, CaMPR, CBPR), and 12 research core resources spanning biostatistics, biomarkers, biomedical informatics, clinical research, community engagement, regulatory/ethics, bionutrition, exposomics, and recruitment/retention.
Product overview
Irving Institute for Clinical and Translational Research is Columbia University's CTSA hub that provides a comprehensive platform of research support services, training programs, and digital tools. The core offering includes the Plan Your Research online navigation tool, Visualization Web Apps (11 tools), and Trial Design and Conduct Web Apps (3 tools). The institute offers multiple career development programs including the Irving Scholars Program (since 1987), KL2 Scholars, TL1 Training Programs, and Precision Medicine Fellows. Additional resources include pilot award programs (Translational Therapeutics Accelerator, Precision Medicine, CaMPR, CBPR), educational workshops (Systematic Review & Meta-analysis Workshop, Columbia Summer Research Institute), and 12 core research resources covering biostatistics, biomarkers, biomedical informatics, community engagement, regulatory support, and more.
Differentiator
Problem solved
Functional benefit
Products and services
- Plan Your Research
- Visualization Web Apps
- Trial Design and Conduct Web Apps
- Systematic Review & Meta-analysis Workshop
- Columbia Summer Research Institute (CSRI)
- Irving Scholars Program
- KL2 Scholars Mentored Career Development Award
- TL1 Training Programs
- Translational Therapeutics Accelerator (TRx) Pilot Awards
- Precision Medicine Pilot Awards
- Community-Based Participatory Research (CBPR) Course
- Collaborative and Multidisciplinary Pilot Research (CaMPR)
- Precision Medicine Fellows
- Biomarkers Core Laboratory (BCL)
- Biomedical Informatics Resource (BMIR)
- Bionutrition Research Core (BRC)
- Biostatistics, Epidemiology, and Research Design (BERD)
- Clinical Research Resource (CRR)
- Community Engagement Core Resource (CECR)
- Network Capacity
- Pilot and Collaborative Studies Resource (PCSR)
- Recruitment & Retention (R&R) Initiative
- Regulatory Knowledge and Support and Ethics Resource (RKSER)
- Training and Education (TRANSFORM)
- Columbia Community Partnership for Health
Quantifiable outcome
- Over $1 million in seed funding awarded to 38 pilot projects
- +2 more outcomes
Companies that use Irving Institute for Clinical and Translational Research
Customer profileNamed customers5 records
Segments4 records
Ideal customer profiles4 records
Irving Institute for Clinical and Translational Research technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature2 records
Irving Institute for Clinical and Translational Research partnerships and signals
Strategic signalPartnerships
Nine partnerships are on record, tiered core and minor.
- Center for Healing of Opioid and Other Substance Use Disorders (CHOSEN)coreLaunched in 2020 as a multidisciplinary center in partnership with Columbia University School of Social Work and New York State Psychiatric Institute's Division on Substance Use Disorders to combat opioid and substance use disorders in NYC and New York State.
- Columbia University Schools and DepartmentscorePartnership with multiple schools including Engineering, Nursing, Dentistry, Social Work, Psychology, Business, and Chemistry, as well as Columbia University Irving Medical Center.
- National Center for Advancing Translational Sciences (NCATS)coreThe institute operates as a CTSA hub supported by NCATS at the NIH, receiving approximately $75 million to advance healthcare discoveries through translational research.
- Clinical and Translational Science Awards (CTSA) Program NetworkcoreThe institute collaborates with CTSA hubs across the United States as part of the national consortium of academic medical centers advancing translational research.
- Department of Biostatistics at Mailman School of Public HealthcoreBERD (Biostatistics, Epidemiology, and Research Design) Resource provides design, statistical, analytical, and database management support in conjunction with this department.
- Department of Epidemiology at Mailman School of Public HealthcoreFaculty members from the Department of Epidemiology contribute to the BERD Resource, providing expertise in epidemiological research design.
- NewYork-Presbyterian HospitalcoreCollaborates with the hospital on research initiatives including the Columbia Opioid Symposium and community health programs.
- New York State Psychiatric InstitutecorePartners with the institute's Division on Substance Use Disorders for opioid crisis response initiatives and research.
- Herbert Irving Comprehensive Cancer Center (HICCC)minorCollaborated on Clinical Trials Day Fair 2026 celebration of clinical research professionals.
Scale indicators6 records
Recent moves7 records
Expansion highlights6 records
Irving Institute for Clinical and Translational Research competitors and assessment
Company assessmentDirect peers
- Harvard Catalyst | The Harvard Clinical and Translational Science Center: Harvard's CTSA hub providing clinical and translational research infrastructure, pilot funding, training programs (KL2/TL1), and core services to Harvard-affiliated investigators. Directly comparable as a peer CTSA hub with analogous scope, NIH funding model, and service portfolio to the Irving Institute.
- Michigan Institute for Clinical and Health Research (MICHR): University of Michigan's CTSA hub providing translational research infrastructure, KL2/TL1 training, and pilot funding. Direct peer under the NIH CTSA program with similar institutional structure and service portfolio.
- NYU Langone Health Clinical and Translational Science Institute: NYU's CTSA hub offering biostatistics, biomedical informatics, pilot awards, and training programs to NYU investigators. The closest geographic peer to the Irving Institute and operates under the same NIH CTSA funding mechanism serving an NYC academic medical center.
- Johns Hopkins Institute for Clinical and Translational Research: Johns Hopkins's CTSA hub with a comprehensive portfolio of cores, KL2/TL1 training, and pilot funding for translational research. Closely comparable in mission, structure, and NIH funding model to the Irving Institute.
- Tufts Clinical and Translational Science Institute: Tufts's CTSA hub providing translational research services, KL2/TL1 training, and pilot awards. A direct peer under the NIH CTSA program serving a comparable academic medical center research community.
- University of Chicago Institute for Translational Medicine: University of Chicago's CTSA hub delivering clinical and translational research support, training, and community engagement. Operates with the same NIH CTSA grant mechanism and offers comparable cores and pilot programs.
- Washington University Institute of Clinical and Translational Sciences: Washington University in St. Louis's CTSA hub delivering translational research support, training programs, and core resources. Direct peer with the same NIH CTSA funding structure and translational science mission.
- Vanderbilt Institute for Clinical and Translational Research: Vanderbilt's CTSA hub offering pilot funding, training, biostatistics, and research navigation services. A direct peer as another major academic CTSA hub with comparable NIH funding and translational scope.
- UCSF Clinical and Translational Science Institute: UCSF's CTSA hub offering translational research services, training, and pilot funding. Direct peer operating under the same NIH CTSA framework with a comparable suite of cores and career development programs.
Peers
- Duke Clinical and Translational Science Institute: Duke's CTSA hub providing translational research support, pilot awards, training programs, and core resources to Duke investigators. A direct peer as a CTSA-funded translational research institute with similar scope and structure.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Irving Institute for Clinical and Translational Research social profiles
Digital presenceIrving Institute for Clinical and Translational Research compliance and trust
Trust signalCompliance1 record
Irving Institute for Clinical and Translational Research financial estimates
Financial estimateRevenue estimate
Valuation estimate
Irving Institute for Clinical and Translational Research leadership team
Management profileNumber of profiles
Profiles14 records
Irving Institute for Clinical and Translational Research subsidiaries and ownership
Company hierarchySubsidiaries10 records
Irving Institute for Clinical and Translational Research funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Irving Institute for Clinical and Translational Research M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Irving Institute for Clinical and Translational Research
What does Irving Institute for Clinical and Translational Research do?
The Irving Institute for Clinical and Translational Research serves as Columbia University's Clinical and Translational Science Awards (CTSA) hub, providing integrated research support services, training programs, pilot funding mechanisms, and digital navigation tools to accelerate the translation of scientific discoveries from bench to bedside to community. Its core offerings include the Plan Your Research online tool, visualization and trial design web applications, multiple career development awards (Irving Scholars, KL2, TL1, Precision Medicine Fellows), pilot award programs (TRx, Precision Medicine, CaMPR, CBPR), and 12 research core resources spanning biostatistics, biomarkers, biomedical informatics, clinical research, community engagement, regulatory/ethics, bionutrition, exposomics, and recruitment/retention.
Is Irving Institute for Clinical and Translational Research a public or private company?
Irving Institute for Clinical and Translational Research is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was Irving Institute for Clinical and Translational Research founded?
Irving Institute for Clinical and Translational Research was founded in 2004. It employs 11 to 50 people.
Where is Irving Institute for Clinical and Translational Research based?
Irving Institute for Clinical and Translational Research is headquartered in New York, United States, in the North America region.
How does Irving Institute for Clinical and Translational Research make money?
One revenue line is on record: NIH CTSA Grant Funding.
Who are Irving Institute for Clinical and Translational Research's main competitors?
Direct peers on record are Harvard Catalyst | The Harvard Clinical and Translational Science Center, Michigan Institute for Clinical and Health Research (MICHR), NYU Langone Health Clinical and Translational Science Institute, Johns Hopkins Institute for Clinical and Translational Research, Tufts Clinical and Translational Science Institute, University of Chicago Institute for Translational Medicine, Washington University Institute of Clinical and Translational Sciences, Vanderbilt Institute for Clinical and Translational Research and UCSF Clinical and Translational Science Institute. Duke Clinical and Translational Science Institute is listed as a peer.
Does Irving Institute for Clinical and Translational Research have an API?
No public API is recorded for Irving Institute for Clinical and Translational Research.
What industry is Irving Institute for Clinical and Translational Research in?
Irving Institute for Clinical and Translational Research's product category is Academic Clinical and Translational Research Services. Its primary akta.pro industry code is HLAIALAF, Translational Medicine & Biomarkers, with a secondary code of HLAGAJAM, Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF). Its NAICS code is 541714 and its SIC code is 8731.